GLP-1 agonists and Face Aging: Decoding Effects with Ex Vivo Facial Models

Understanding and countering facial tissue effects with our unique donor ex vivo models The rise of GLP-1 agonists is revolutionizing obesity management, but has revealing a major aesthetic side effect in clinical practice, the so-called « GLP-1 Face » or « Ozempic Face. » At ExAdEx-Innov, we decode these mechanisms using our exclusive ex vivo model of human facial […]